1. Japan Stocks

  2. •

    Industrials

  3. •

    Industrial - Pollution & Treatment Controls
Organo Corporation

Organo Corporation

ORGJF
Organo CorporationUS flagOther OTC
100.46
USD
- -
- -
4.62BMarket Cap

Total Valuation

Organo Corporation carries a market capitalization of 4.62B, placing it among publicly traded companies globally. Its enterprise value stands at 152.43B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.62B
Enterprise Value152.43B

Share Statistics

Organo Corporation currently has 46.00M shares outstanding.

Shares Outstanding46.00M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Organo Corporation trades at a trailing price-to-earnings ratio of 15.15. The price-to-sales ratio is 2.10, and the price-to-book ratio stands at 1.85.

PE Ratio15.15
PS Ratio2.10
PB Ratio1.85
P/TBV Ratio1.66
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Organo Corporation trades at an EV/EBITDA multiple of 10.38 and an EV/FCF ratio of 1,468.08. The EV/Sales ratio of 1.80 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.38 provides insight into valuation relative to core operating earnings.

EV / Sales1.80
EV / EBITDA10.38
EV / EBIT10.38
EV / FCF1,468.08

Financial Position

Organo Corporation maintains a current ratio of 2.33, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.83, indicating elevated leverage, while an interest coverage ratio of 110.44 demonstrates strong ability to service its debt obligations.

Current Ratio2.33
Quick Ratio0.80
Debt / Equity23.83
Debt / EBITDA1.76
Interest Coverage110.44

Financial Efficiency

Organo Corporation posts a return on equity of 13.25 and a return on invested capital of 8.57.

Return on Equity (ROE)13.25
Return on Assets (ROA)6.70
Return on Invested Capital (ROIC)8.57
Return on Capital Employed (ROCE)9.93
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.28

Taxes

Over the trailing twelve months, Organo Corporation has paid 3.31B in income taxes, reflecting an effective tax rate of 21.93.

Income Tax3.31B
Effective Tax Rate21.93

Stock Price Statistics

Organo Corporation's stock has gained approximately 89.43994% over the past 52 weeks. The 50-day moving average sits at 100.46, while the 200-day moving average is 78.85.

Beta (5Y)N/A
52-Week Price Change89.43994%
50-Day Moving Average100.46
200-Day Moving Average78.85
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Organo Corporation generated 84.89B in revenue and converted that into 11.77B in net income, yielding earnings per share of 256.68. EBITDA reached 14.69B, while operating income came in at 14.69B.

Revenue84.89B
Gross Profit25.71B
Operating Income14.69B
Pretax Income15.11B
Net Income11.77B
EBITDA14.69B
EBIT14.69B
Earnings Per Share (EPS)256.68

Balance Sheet

Organo Corporation holds 51.97B in cash and equivalents against 25.85B in total debt, resulting in a net debt position of 9.18B. Total book value stands at 96.46B, with working capital of 86.39B providing operational flexibility.

Cash & Cash Equivalents51.97B
Total Debt25.85B
Net Debt9.18B
Equity (Book Value)96.46B
Book Value Per Share2,099.46
Working Capital86.39B

Margins

Organo Corporation operates with a gross margin of 30.29, reflecting its pricing power and cost economics. The operating margin of 17.30 and net profit margin of 13.87 provide insight into operational efficiency.

Gross Margin30.29
Operating Margin17.30
Pretax Margin17.80
Profit Margin13.87
EBITDA Margin17.30

Stock Splits

Organo Corporation's most recent stock split took place on September 29, 2022 with a 1:4 split ratio.

Last Split Date9/29/2022
Split Ratio1:4

Scores

Organo Corporation posts an Altman Z-Score of 3.48, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.48